Showing results (721-730 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|April 15, 2018
Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination TherapyAnnie Moisan, Francesca Michielin, Wolfgang Jacob, et al.
Molecular Cancer Therapeutics|March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancerMarcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
Molecular Cancer Therapeutics|March 12, 2009
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapyJinming Yang, Snjezana Zaja-Milatovic, Yee-Mon Thu, et al.
Molecular Cancer Therapeutics|March 5, 2009
Molecular imaging of Bcr-Abl phosphokinase in a xenograft modelJi Yuan Wu, David J Yang, Laura S Angelo, et al.
Molecular Cancer Therapeutics|March 5, 2009
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcomaFrancesco Marampon, Gianluca Bossi, Carmela Ciccarelli, et al.
Molecular Cancer Therapeutics|May 14, 2009
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistanceTaiki Moriyama, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.
Molecular Cancer Therapeutics|May 14, 2009
Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatmentKyunghee Burkitt, Sang Y Chun, Duyen T Dang, et al.
Molecular Cancer Therapeutics|February 26, 2009
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2Siting Feng, Qizhu Tang, Meng Sun, et al.
Molecular Cancer Therapeutics|February 26, 2009
Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screeningAgnieszka B Bialkowska, Yuhong Du, Haian Fu, et al.
Molecular Cancer Therapeutics|April 23, 2009
The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectivesYves Pommier, Mark Cushman
Pageof 599